Residual TP53 Mutation Contributes to Chemoresistance through Clonal Expansion in Acute Myeloid Leukemia

被引：1

作者：

Yan, Bowen ^{[1
]}

Chen, Qinwei ^{[1
]}

Xu, Jianfeng ^{[2
]}

Li, Wei ^{[2
]}

Xu, Bing ^{[3
]}

Huang, Suming ^{[4
]}

Qiu, Yi ^{[1
]}

机构：

[1] Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL USA

[2] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA

[3] Xiamen Univ, Dept Hematol, Affiliated Hosp 1, Xiamen, Peoples R China

[4] Penn State Univ, Hershey Coll Med, Dept Pediat, Div Hematol & Oncol,Penn State Canc Inst, Hershey, PA USA

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-127511

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2731

引用

页数：3

共 50 条

[41] Prognostic heterogeneity and clonal dynamics within distinct subgroups of myelodysplastic syndrome and acute myeloid leukemia with TP53 disruptions
Patel, Shyam A.
Cerny, Jan
Gerber, William K.
Ramanathan, Muthalagu
Ediriwickrema, Asiri
Tanenbaum, Benjamin
Hutchinson, Lloyd
Meng, Xiuling
Flahive, Julie
Barton, Bruce
Gillis-Smith, Andrew J.
Suzuki, Sakiko
Khedr, Salwa
Selove, William
Higgins, Anne W.
Miron, Patricia M.
Simin, Karl
Woda, Bruce
Gerber, Jonathan M.
EJHAEM, 2023, 4 (04): : 1059 - 1070
[42] Mediastinal Myeloid Sarcoma with TP53 Mutation Preceding Acute Myeloid Leukemia with a PICALM-MLLT10 Fusion Gene
Naesens, Leslie
Devos, Helena
Nollet, Friedel
Michaux, Lucienne
Selleslag, Dominik
ACTA HAEMATOLOGICA, 2018, 140 (02) : 97 - 104
[43] The Genotype Consisting of Complex Karyotype and TP53 Gene Mutation Is Specific to Acute Myeloid Leukemia with Multilineage Dysplasia
Ishikawa, Yuichi
Kiyoi, Hitoshi
Tsujimura, Akane
Miyazaki, Yasushi
Tomonaga, Masao
Kuriyama, Kazutaka
Miyawaki, Shuichi
Naoe, Tomoki
BLOOD, 2008, 112 (11) : 870 - 870
[44] iAMP21 in acute myeloid leukemia is associated with complex karyotype, TP53 mutation and dismal outcome
Xie, Wei
Xu, Jie
Hu, Shimin
Li, Shaoying
Wang, Wei
Cameron Yin, C.
Toruner, Gokce
Tang, Zhenya
Jeffrey Medeiros, L.
Tang, Guilin
MODERN PATHOLOGY, 2020, 33 (07) : 1389 - 1397
[45] Identification of key pathways and genes in TP53 mutation acute myeloid leukemia: evidence from bioinformatics analysis
Huang, Rui
Liao, Xiwen
Li, Qiaochuan
ONCOTARGETS AND THERAPY, 2018, 11 : 163 - 173
[46] Transplant versus no transplant in myelodysplastic syndrome and acute myeloid leukemia with TP53 mutation; a referral center experience
Poonsombudlert, Kittika
Mott, Sarah
Miller, Benda
Dhakal, Prajwal
Snow, Anthony
Hornberg, Sarah
Yodsuwan, Ratdanai
Strouse, Christopher
Shaikh, Hira
Magalhaes-Silverman, Margarida
Sutamtewagul, Grerk
EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 113 (01) : 16 - 23
[47] The Occurrence of Infection and TP53 Mutation Are Risk Factors for Cardiovascular Toxicity of Acute Myeloid Leukemia Induction Therapy
Kemp, Helene
Fenwarth, Laurene
Lebon, Delphine
Duployez, Nicolas
Paubelle, Etienne
Joris, Magalie
Charbonnier, Amandine
Montes, Lydia
Preudhomme, Claude
Tribouilloy, Christophe
Marolleau, Jean Pierre
Morel, Pierre
BLOOD, 2023, 142
[48] Association Analyses of TP53 Mutation With Prognosis, Tumor Mutational Burden, and Immunological Features in Acute Myeloid Leukemia
Wen, Xiang-Mei
Xu, Zi-Jun
Jin, Ye
Xia, Pei-Hui
Ma, Ji-Chun
Qian, Wei
Lin, Jiang
Qian, Jun
FRONTIERS IN IMMUNOLOGY, 2021, 12
[49] TP53 mutation acute myeloid Leukemia Cells show a relative Resistance to CAR T Cell Therapy
Muller, J.
Fullin, J.
Schimmer, R.
Manz, M. G.
Boettcher, S.
ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 124 - 124
[50] Karyotype evolution of myelodysplastic syndrome and acute myeloid leukemia with TP53 mutations
Matsumoto, Yosuke
Kato, Daishi
Muramatsu, Ayako
Sugitani, Mio
Kobayashi, Tsutomu
Iwai, Toshiki
Mori, Minako
Motooka, Daisuke
Nakata, Jun
Ogawa, Seishi
Nannya, Yasuhito
Uchiyama, Hitoji
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2025,

← 1 2 3 4 5 →